Signature SBS9 activity (DNA polymerase Pol η associated with activation-induced deaminase [AID]) decreases along with CCF in over half of the tumors in which it is active (Chronic Lymphocytic Leukemia (CLL) and and B cell non-Hodgkin lymphoma). Here, AICDA is linked to B-cell non-Hodgkin lymphoma.